Literature DB >> 26684063

Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies.

Julia S Sisti1,2,3, Laura C Collins4, Andrew H Beck4, Rulla M Tamimi1,2, Bernard A Rosner2, A Heather Eliassen1,2.   

Abstract

Several intrinsic breast cancer subtypes, possibly representing unique etiologic processes, have been identified by gene expression profiles. Evidence suggests that associations with reproductive risk factors may vary by breast cancer subtype. In the Nurses' Health Studies, we prospectively examined associations of reproductive factors with breast cancer subtypes defined using immunohistochemical staining of tissue microarrays. Multivariate-adjusted Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Over follow-up, we identified 2,063 luminal A, 1,008 luminal B, 209 HER2-enriched, 378 basal-like and 110 unclassified tumors. Many factors appeared associated with luminal A tumors, including ages at menarche (p(heterogeneity) = 0.65) and menopause (p(heterogeneity) = 0.05), and current HT use (p(heterogeneity) = 0.33). Increasing parity was not associated with any subtype (p(heterogeneity) = 0.76), though age at first birth was associated with luminal A tumors only (per 1-year increase HR = 1.03 95%CI (1.02-1.05), p(heterogeneity)  = 0.04). Though heterogeneity was not observed, duration of lactation was inversely associated with risk of basal-like tumors only (7+ months vs. never HR = 0.65 95%CI (0.49-0.87), ptrend = 0.02), p(heterogeneity) = 0.27). Years between menarche and first birth was strongly positively associated with luminal A and non-luminal subtypes (e.g. 22-year interval vs. nulliparous HR = 1.80, 95%CI (1.08-3.00) for basal-like tumors; p(heterogeneity) = 0.003), and evidence of effect modification by breastfeeding was observed. In summary, many reproductive risk factors for breast cancer appeared most strongly associated with the luminal A subtype. Our results support previous reports that lactation is protective against basal-like tumors, representing a potential modifiable risk factor for this aggressive subtype.
© 2015 UICC.

Entities:  

Keywords:  breast cancer; lactation; molecular subtypes; pregnancy; reproductive risk factors

Mesh:

Substances:

Year:  2016        PMID: 26684063      PMCID: PMC5245093          DOI: 10.1002/ijc.29968

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  50 in total

1.  Timing of menarche and first full-term birth in relation to breast cancer risk.

Authors:  Christopher I Li; Kathleen E Malone; Janet R Daling; John D Potter; Leslie Bernstein; Polly A Marchbanks; Brian L Strom; Michael S Simon; Michael F Press; Giske Ursin; Ronald T Burkman; Suzanne G Folger; Sandra Norman; Jill A McDonald; Robert Spirtas
Journal:  Am J Epidemiol       Date:  2007-10-26       Impact factor: 4.897

2.  Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study.

Authors:  Seokang Chung; Sue K Park; Hyuna Sung; Nan Song; Wonshik Han; Dong-Young Noh; Sei-Hyun Ahn; Keun-Young Yoo; Ji-Yeob Choi; Daehee Kang
Journal:  Breast Cancer Res Treat       Date:  2013-07-31       Impact factor: 4.872

3.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.

Authors:  T Key; P Appleby; I Barnes; G Reeves
Journal:  J Natl Cancer Inst       Date:  2002-04-17       Impact factor: 13.506

4.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

5.  Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.

Authors:  Torsten O Nielsen; Forrest D Hsu; Kristin Jensen; Maggie Cheang; Gamze Karaca; Zhiyuan Hu; Tina Hernandez-Boussard; Chad Livasy; Dave Cowan; Lynn Dressler; Lars A Akslen; Joseph Ragaz; Allen M Gown; C Blake Gilks; Matt van de Rijn; Charles M Perou
Journal:  Clin Cancer Res       Date:  2004-08-15       Impact factor: 12.531

6.  Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.

Authors:  Wendy Y Chen; Susan E Hankinson; Stuart J Schnitt; Bernard A Rosner; Michelle D Holmes; Graham A Colditz
Journal:  Cancer       Date:  2004-10-01       Impact factor: 6.860

7.  Supervised risk predictor of breast cancer based on intrinsic subtypes.

Authors:  Joel S Parker; Michael Mullins; Maggie C U Cheang; Samuel Leung; David Voduc; Tammi Vickery; Sherri Davies; Christiane Fauron; Xiaping He; Zhiyuan Hu; John F Quackenbush; Inge J Stijleman; Juan Palazzo; J S Marron; Andrew B Nobel; Elaine Mardis; Torsten O Nielsen; Matthew J Ellis; Charles M Perou; Philip S Bernard
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

Review 8.  Differentiation of the mammary gland and susceptibility to carcinogenesis.

Authors:  J Russo; L K Tay; I H Russo
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

9.  Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health Study.

Authors:  Christine B Ambrosone; Gary Zirpoli; Melanie Ruszczyk; Jyoti Shankar; Chi-Chen Hong; Demetra McIlwain; Michelle Roberts; Song Yao; Susan E McCann; Gregory Ciupak; Helena Hwang; Thaer Khoury; Lina Jandorf; Dana H Bovbjerg; Karen Pawlish; Elisa V Bandera
Journal:  Cancer Causes Control       Date:  2013-11-19       Impact factor: 2.506

10.  Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry.

Authors:  E C Inwald; M Klinkhammer-Schalke; F Hofstädter; F Zeman; M Koller; M Gerstenhauer; O Ortmann
Journal:  Breast Cancer Res Treat       Date:  2013-05-16       Impact factor: 4.872

View more
  53 in total

1.  Breast cancer risk prediction: an update to the Rosner-Colditz breast cancer incidence model.

Authors:  Megan S Rice; Shelley S Tworoger; Susan E Hankinson; Rulla M Tamimi; A Heather Eliassen; Walter C Willett; Graham Colditz; Bernard Rosner
Journal:  Breast Cancer Res Treat       Date:  2017-07-12       Impact factor: 4.872

Review 2.  Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.

Authors:  Tsuyoshi Hamada; NaNa Keum; Reiko Nishihara; Shuji Ogino
Journal:  J Gastroenterol       Date:  2016-10-13       Impact factor: 7.527

3.  Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study.

Authors:  Lindsay A Williams; Hazel B Nichols; Katherine A Hoadley; Chiu Kit Tse; Joseph Geradts; Mary Elizabeth Bell; Charles M Perou; Michael I Love; Andrew F Olshan; Melissa A Troester
Journal:  Cancer Causes Control       Date:  2017-11-09       Impact factor: 2.506

Review 4.  Is There Etiologic Heterogeneity between Subtypes of Childhood Acute Lymphoblastic Leukemia? A Review of Variation in Risk by Subtype.

Authors:  Lindsay A Williams; Jun J Yang; Betsy A Hirsch; Erin L Marcotte; Logan G Spector
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-02-15       Impact factor: 4.254

5.  Dioxin exposure and breast cancer risk in a prospective cohort study.

Authors:  Trang VoPham; Kimberly A Bertrand; Rena R Jones; Nicole C Deziel; Natalie C DuPré; Peter James; Ying Liu; Verónica M Vieira; Rulla M Tamimi; Jaime E Hart; Mary H Ward; Francine Laden
Journal:  Environ Res       Date:  2020-04-13       Impact factor: 6.498

6.  Particulate Matter and Traffic-Related Exposures in Relation to Breast Cancer Survival.

Authors:  Natalie C DuPré; Jaime E Hart; Michelle D Holmes; Elizabeth M Poole; Peter James; Peter Kraft; Francine Laden; Rulla M Tamimi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-15       Impact factor: 4.254

7.  Differential Patterns of Risk Factors for Early-Onset Breast Cancer by ER Status in African American Women.

Authors:  Kimberly A Bertrand; Traci N Bethea; Lucile L Adams-Campbell; Lynn Rosenberg; Julie R Palmer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-10-18       Impact factor: 4.254

8.  Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries.

Authors:  Andrea M Austin; Nirav S Kapadia; Gabriel A Brooks; Tracy L Onega; A Heather Eliassen; Rulla M Tamimi; Michelle Holmes; Qianfei Wang; Francine Grodstein; Anna N A Tosteson
Journal:  Breast Cancer Res Treat       Date:  2019-01-03       Impact factor: 4.872

Review 9.  Breast Cancer Research in the Nurses' Health Studies: Exposures Across the Life Course.

Authors:  Megan S Rice; A Heather Eliassen; Susan E Hankinson; Elizabeth B Lenart; Walter C Willett; Rulla M Tamimi
Journal:  Am J Public Health       Date:  2016-07-26       Impact factor: 9.308

10.  Prospective study of a diabetes risk reduction diet and the risk of breast cancer.

Authors:  Jae H Kang; Cheng Peng; Jinnie J Rhee; Maryam S Farvid; Walter C Willett; Frank B Hu; Bernard A Rosner; Rulla Tamimi; A Heather Eliassen
Journal:  Am J Clin Nutr       Date:  2020-12-10       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.